A 73-year-old prostate cancer patient at Institut Catala dOncologia in Barcelona, Spain was the first individual in the country to be treated with RapidArc radiotherapy from Varian Medical Systems.

The FDA has approved GE Healthcares Cysview (hexaminolevulinate HCl) for the detection of non-muscle-invasive papillary cancer of the bladder in patients with known or suspected bladder cancer.

In observing various treatment modalities for primary adenocarcinoma of the bladder, researchers from Henry Ford Hospital in Detroit determined that radiation therapy may not improve a patient's chances for survival.

The American College of Radiology (ACR) is urging Congress to pass the Virtual Screening for Colorectal Cancer Act of 2010 (H.R. 5461) which would require the Centers for Medicare & Medicaid Services (CMS) to provide coverage of screening CT colonography, or virtual colonoscopy, to Medicare beneficiaries.

Radiotherapy product developer Resonant Medical is collaborating with U.S. group purchasing organization Amerinet for the purchasing of Resonants image-guided radiation therapy technology, the Clarity System.

Radiosurgery developer Accuray has installed the newest product on its CyberKnife line, the CyberKnife VSI System at Creekside Cancer Care in Lafayette, Colo.

GE Healthcare has introduced its SenoBright contrast-enhanced spectral mammography technology, which uses x-rays at multiple energies to create two separate exposures.

Elekta is seeking to acquire Resonant Medical for $28.5 million in cash for the outstanding shares of Resonant, in order to add image guidance technologies, as well as R&D resources in the field of oncology imaging and motion management to its portfolio.